Bioactive Components and Potential Mechanism Prediction of Kui Jie Kang against Ulcerative Colitis via Systematic Pharmacology and UPLC-QE-MS Analysis

<div>Analysis of UC treatment with KJK using gene ontology (GO) and pathway enrichment analyses. (a) GO enrichment analysis for the key targets. (b) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of the key targets. (c) The KJK active ingredient-UC target pathway network. Green circle: target gene; green diamond: active ingredient; green square: TCM; blue arrow head: pathways.</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Bioactive Components and Potential Mechanism Prediction of Kui Jie Kang against Ulcerative Colitis via Systematic Pharmacology and UPLC-QE-MS Analysis 

Figure 3 | Bioactive Components and Potential Mechanism Prediction of Kui Jie Kang against Ulcerative Colitis via Systematic Pharmacology and UPLC-QE-MS Analysis 